012 Efficacy and Safety of Ixekizumab in a Randomized, Double-Blinded, Placebo-Controlled, Phase 3b Clinical Trial in Patients with Moderate-to-Severe Genital Psoriasis. (1st February 2018) - Ryan, C.; Menter, A.; Guenther, L.; Blauvelt, A.; Bissonnette, R.; Yang, F.E.; Potts Bleakman, A.